Analysis of the National LymphoCare Study Evaluating Early Disease Progression in Patients with FL within 2 Years of R-CHOP


Analysis of the National LymphoCare Study Evaluating Early Disease Progression in Patients with FL within 2 Years of R-CHOP
Slides from a presentation at ASH 2013 and transcribed comments from a recent interview with Andrew M Evens, DO, MSc (2/12/14)
Casulo C et al. Early relapse of follicular lymphoma after R-CHOP uniquely defines patients at high risk for death: An analysis from the National Lymphocare Study. Proc ASH 2013;Abstract 510.

Dr Evens is Professor of Medicine and Chief of the Division of Hematology/Oncology at Tufts Medical Center and Director of the Lymphoma Program and Interim Director at Tufts Cancer Center in Boston, Massachusetts.